Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Etoricoxib Intermediate market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Etoricoxib Intermediatemarket, defines the market attractiveness level of Etoricoxib Intermediate market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Etoricoxib Intermediate industry, describes the types of Etoricoxib Intermediate market, the applications of major players and the market size, and deeply analyzes the current situation of the global Etoricoxib Intermediate market and the development prospects and opportunities of Etoricoxib Intermediate industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Etoricoxib Intermediate market in Chapter 13.
By Player:
Merck
Perrigo
Bayer
GlaxoSmithKline
Novacap
Geri-Care
Pfizer
Kopran
Abbott
Sun Pharmaceutical
By Type:
n-House Manufacturing
Contract Manufacturing Organizations
By End-User:
Rheumatoid Arthritis
Psoriatic Arthritis
Osteoarthritis
Ankylosing Spondylitis
Chronic Low Back Pain
Acute Pain
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Etoricoxib Intermediate Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Etoricoxib Intermediate Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Etoricoxib Intermediate Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Etoricoxib Intermediate Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Etoricoxib Intermediate Market Analysis and Outlook to 2022
-
7.1 Global Etoricoxib Intermediate Consumption (2017-2022)
-
7.2 United States Etoricoxib Intermediate Consumption (2017-2022)
-
7.3 Europe Etoricoxib Intermediate Consumption (2017-2022)
-
7.4 China Etoricoxib Intermediate Consumption (2017-2022)
-
7.5 Japan Etoricoxib Intermediate Consumption (2017-2022)
-
7.6 India Etoricoxib Intermediate Consumption (2017-2022)
-
7.7 South Korea Etoricoxib Intermediate Consumption (2017-2022)
8 Region and Country-wise Etoricoxib Intermediate Market Analysis and Outlook to 2028
-
8.1 Global Etoricoxib Intermediate Consumption Forecast (2022-2028)
-
8.2 United States Etoricoxib Intermediate Consumption Forecast (2022-2028)
-
8.3 Europe Etoricoxib Intermediate Consumption Forecast (2022-2028)
-
8.4 China Etoricoxib Intermediate Consumption Forecast (2022-2028)
-
8.5 Japan Etoricoxib Intermediate Consumption Forecast (2022-2028)
-
8.6 India Etoricoxib Intermediate Consumption Forecast (2022-2028)
-
8.7 South Korea Etoricoxib Intermediate Consumption Forecast (2022-2028)
9 Global Etoricoxib Intermediate Market Outlook by Types and Applications to 2022
-
9.1 Global Etoricoxib Intermediate Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global n-House Manufacturing Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Contract Manufacturing Organizations Consumption and Growth Rate (2017-2022)
-
9.2 Global Etoricoxib Intermediate Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Rheumatoid Arthritis Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Psoriatic Arthritis Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Osteoarthritis Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Ankylosing Spondylitis Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Chronic Low Back Pain Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Acute Pain Consumption and Growth Rate (2017-2022)
-
9.2.7 Global Others Consumption and Growth Rate (2017-2022)
10 Global Etoricoxib Intermediate Market Outlook by Types and Applications to 2028
-
10.1 Global Etoricoxib Intermediate Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global n-House Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Contract Manufacturing Organizations Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Etoricoxib Intermediate Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Rheumatoid Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Psoriatic Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Ankylosing Spondylitis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Chronic Low Back Pain Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Acute Pain Consumption Forecast and Growth Rate (2022-2028)
-
10.2.7 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Etoricoxib Intermediate Import and Export Analysis (Top 5 Countries)
-
11.1 Global Etoricoxib Intermediate Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Etoricoxib Intermediate Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Etoricoxib Intermediate Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Etoricoxib Intermediate Market Competitive Analysis
-
14.1 Merck
-
14.1.1 Merck Company Details
-
14.1.2 Merck Etoricoxib Intermediate Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Merck Etoricoxib Intermediate Product and Service
-
14.2 Perrigo
-
14.2.1 Perrigo Company Details
-
14.2.2 Perrigo Etoricoxib Intermediate Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Perrigo Etoricoxib Intermediate Product and Service
-
14.3 Bayer
-
14.3.1 Bayer Company Details
-
14.3.2 Bayer Etoricoxib Intermediate Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bayer Etoricoxib Intermediate Product and Service
-
14.4 GlaxoSmithKline
-
14.4.1 GlaxoSmithKline Company Details
-
14.4.2 GlaxoSmithKline Etoricoxib Intermediate Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 GlaxoSmithKline Etoricoxib Intermediate Product and Service
-
14.5 Novacap
-
14.5.1 Novacap Company Details
-
14.5.2 Novacap Etoricoxib Intermediate Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Novacap Etoricoxib Intermediate Product and Service
-
14.6 Geri-Care
-
14.6.1 Geri-Care Company Details
-
14.6.2 Geri-Care Etoricoxib Intermediate Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Geri-Care Etoricoxib Intermediate Product and Service
-
14.7 Pfizer
-
14.7.1 Pfizer Company Details
-
14.7.2 Pfizer Etoricoxib Intermediate Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Pfizer Etoricoxib Intermediate Product and Service
-
14.8 Kopran
-
14.8.1 Kopran Company Details
-
14.8.2 Kopran Etoricoxib Intermediate Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Kopran Etoricoxib Intermediate Product and Service
-
14.9 Abbott
-
14.9.1 Abbott Company Details
-
14.9.2 Abbott Etoricoxib Intermediate Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Abbott Etoricoxib Intermediate Product and Service
-
14.10 Sun Pharmaceutical
-
14.10.1 Sun Pharmaceutical Company Details
-
14.10.2 Sun Pharmaceutical Etoricoxib Intermediate Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Sun Pharmaceutical Etoricoxib Intermediate Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Etoricoxib Intermediate
-
Figure Etoricoxib Intermediate Picture
-
Table Global Etoricoxib Intermediate Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Etoricoxib Intermediate Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Etoricoxib Intermediate Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Etoricoxib Intermediate Consumption by Country (2017-2022)
-
Figure United States Etoricoxib Intermediate Consumption and Growth Rate (2017-2022)
-
Table Europe Etoricoxib Intermediate Consumption and Growth Rate (2017-2022)
-
Figure China Etoricoxib Intermediate Consumption and Growth Rate (2017-2022)
-
Figure Japan Etoricoxib Intermediate Consumption and Growth Rate (2017-2022)
-
Figure India Etoricoxib Intermediate Consumption and Growth Rate (2017-2022)
-
Figure South Korea Etoricoxib Intermediate Consumption and Growth Rate (2017-2022)
-
Figure Global Etoricoxib Intermediate Consumption Forecast by Country (2022-2028)
-
Figure United States Etoricoxib Intermediate Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Etoricoxib Intermediate Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Etoricoxib Intermediate Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Etoricoxib Intermediate Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Etoricoxib Intermediate Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Etoricoxib Intermediate Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global n-House Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure Global Contract Manufacturing Organizations Consumption and Growth Rate (2017-2022)
-
Figure Global Rheumatoid Arthritis Consumption and Growth Rate (2017-2022)
-
Figure Global Psoriatic Arthritis Consumption and Growth Rate (2017-2022)
-
Figure Global Osteoarthritis Consumption and Growth Rate (2017-2022)
-
Figure Global Ankylosing Spondylitis Consumption and Growth Rate (2017-2022)
-
Figure Global Chronic Low Back Pain Consumption and Growth Rate (2017-2022)
-
Figure Global Acute Pain Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global n-House Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Contract Manufacturing Organizations Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rheumatoid Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Psoriatic Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ankylosing Spondylitis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chronic Low Back Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Acute Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Etoricoxib Intermediate Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Etoricoxib Intermediate Export by Region (Top 5 Countries) (2017-2028)
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Etoricoxib Intermediate Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Etoricoxib Intermediate Product and Service
-
Table Perrigo (Foundation Year, Company Profile and etc.)
-
Table Perrigo Etoricoxib Intermediate Sales, Price, Value and Gross Profit (2017-2022)
-
Table Perrigo Etoricoxib Intermediate Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Etoricoxib Intermediate Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Etoricoxib Intermediate Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Etoricoxib Intermediate Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Etoricoxib Intermediate Product and Service
-
Table Novacap (Foundation Year, Company Profile and etc.)
-
Table Novacap Etoricoxib Intermediate Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novacap Etoricoxib Intermediate Product and Service
-
Table Geri-Care (Foundation Year, Company Profile and etc.)
-
Table Geri-Care Etoricoxib Intermediate Sales, Price, Value and Gross Profit (2017-2022)
-
Table Geri-Care Etoricoxib Intermediate Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Etoricoxib Intermediate Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Etoricoxib Intermediate Product and Service
-
Table Kopran (Foundation Year, Company Profile and etc.)
-
Table Kopran Etoricoxib Intermediate Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kopran Etoricoxib Intermediate Product and Service
-
Table Abbott (Foundation Year, Company Profile and etc.)
-
Table Abbott Etoricoxib Intermediate Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Etoricoxib Intermediate Product and Service
-
Table Sun Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Sun Pharmaceutical Etoricoxib Intermediate Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sun Pharmaceutical Etoricoxib Intermediate Product and Service
-
